ASReview
Cross-source consensus on ASReview from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Comparisons
Evidence quality
Highlighted claims
- The protocol uses ASReview, an open-source AI tool based on natural language processing. — Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods
- ASReview learns from inclusion and exclusion decisions and prioritises abstracts by predicted relevance. — Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods
- The AI-assisted screening approach must be internally validated against manual screening before use in the main review process. — Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods
- The ASReview validation set stops after 200 consecutive abstracts without an inclusion or after all 1000 abstracts are screened. — Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods
- If validation fails, the team will assess other NLP-assisted methods or consider a fully manual review. — Long-term infection risks in haematological cancer survivors compared with individuals with no cancer history: protocol for a systematic review aided by artificial intelligence-based methods